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Abstract – We develop a completely integrated Lab-on-Chip (LoC) 
for easy, rapid and cost-effective immunoassays. The pathogen 
sensing system is composed of a microfluidic channel surrounded by 
planar microcoils which are responsible for the emission and the 
detection of magnetic fields. The system allows the detection and 
quantification of superparamagnetic beads used for immunoassays 
in a “sandwich” antigen-antibody configuration. We successfully 
tested this device with different concentrations of nanoparticles and 
determine the limit of detection of the prototype. These results are 
promising and are a step toward the creation of a portable pathogen 
sensing device. 
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I. INTRODUCTION 
Ever-increasing number of people traveling on airplanes 
leads to the rapid spread of diseases worldwide and enhanced 
risks of pandemics. So there is a need for a rapid, sensitive, 
reliable, low-cost, and portable system for nomadic 
applications of pathogen detection. Moreover, the detection of 
a biological agent or entity and the determination of its 
concentration can be crucial for anticipating possible health 
threats, whether epidemic or pandemic, environmental threats, 
or to combat other contextual threats, including bioterrorism, 
or chemical and biological weapons. To achieve this objective, 
designing and generating embedded microsystems composed 
of innovative sensors is necessary [1-2]. Many attempts have 
been made to develop LoC systems. Among them, 
electrochemical and optical based methods dominate; however, 
they often suffer from drawbacks such as a nonlinear detection 
range, a lack of sensitivity, non-specific detection, and 
complexity of integration [3-5]. Other methods include 
mechanical [6-7] and magnetic detection approaches. The latter 
holds promise due to their miniaturization possibility [8-11]. 
The LoC system we designed is based on the development of 
a simple, cost effective system using magnetic detection, 
taking advantage of the nonlinearity of superparamagnetic 
nanoparticles (SPN). Biological analysis with high sensitivity 
magnetic measurements is a new type of immunochemical 
diagnosis using SPN as markers instead of conventional 
enzymes, radioisotopes or fluorescent compounds [12-13]. 
This novel method of analysis, which can be miniaturized, 
involves the covalent ligation of biomarker-specific 
monoclonal antibodies to SPN. The presence of SPN is then 
detected by the frequency mixing method (Figure 1) which 
consists in the use of two distinct excitation frequencies and 
the reading and quantification of the mixed frequency signals 
indicative of the magnetic non-linearity of the 
superparamagnetic nanoparticles [14-16]. This technique 
makes it possible to envisage a rapid, portable and cheap 
pathogen detection method [17]. 
 
Figure 1. (a) Principle of detection of the proposed structure. (b) Magnetic 
excitation field with tow low and hight frequencies. (c) Resulting magnetic 
flux density. (d) Fourier transform of the detected signal. In red, the selected 
mixing term for the detection of SPNs is marked. 
II. DEVICE PROTOTYPE FOR SPN DETECTION 
A.   Device architecture 
 
A PCB/microfluidic prototype was developed. The structure 
is composed of 4 copper multilayer coils: three coils emit the 
electromagnetic field, two for low frequency and the other for 
high frequency, the fourth one is the detection coil. These coils 
are contained in two PCB structures ( ) 
surrounding above and under the serpentine like microfluidic 
channel ( which can contain 14 µL of magnetic 
nanoparticles solution. Each coil is composed of four layers; 
the tracks are 100 µm wide with an inter-distance of 100 µm. 
Each layer of track has a thickness of 35 µm. The emitting 
coils have a radius of 13 mm (60 turns/layer) and the detection 
coil has a radius of 10 mm (46 turns/layer). Because both the 
excitation and pick-up coils are made in the same PCB, we had 
to balance the above mentioned criteria for proper 
magnetization and detection. In the case of this validation 
process, the distance between the PCBs is 4 mm and the 
distance between the detection coil (lower PCB) and the 
microfluidic chamber is 1 mm. Two sets of PCB/microfluidic 
are used, one for the measurement and the other one for 
reference. They are linked in order to subtract the signal 
detected with the sample and the signal detected with the 
reference to get a precise gradiometric measurement of the 
difference (Figure 2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. (a) Schematic description of the layers (front view): the two green 
blocks represent the two PCBs containing the coils (LF: Low Frequency, S: 
Sensor and HF: High Frequency), the grey part represents the PDMS layers 
which contains the microfluidic channel (the yellow part) and which is bonded 
to a glass slide (in blue). (b) Picture of the PCB/ microfluidic first prototype 
detection structure. 
B.   Detection of superparamagnetic nanoparticles 
 
The sensitivity response of the structure was tested with 
respect to the concentration of the SPNs. For these experiments 
the low frequency is 80 Hz with a coil voltage of 14 V and the 
high frequency is 40 kHz with a voltage of 15 V. The response 
signal of the detection coil is amplified by a factor of 500 using 
a standard lock-in amplifier. Different concentrations of iron 
oxide nanoparticles (Fe2O3) suspensions were used to validate 
the detection technique and determine the limit of detection 
(LoD) of the structure. The core of the SPNs is 20 nm in mean 
diameter. The magnetic response as a function of the mass 
concentration of iron oxide nanoparticles is shown in Figure 3. 
The amplitude of the detected signal is linear with the 
concentrations of the nanoparticles for a linear range of 2 
orders of magnitude. Furthermore, the tests were repeated at 
day’s interval and proved to be very reproducible. With an 
accepted error of less than 15 %, the limit of detection is about 
15 ng/µL.  
Furthermore, other types and sizes of nanoparticles were 
successfully detected using this device. Different microfluidic 
chambers were also tried to optimize the voltage response. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Magnetic response as a function of the mass concentration of 20 nm 
Fe2O3 nanoparticles. The red dotted line indicates the calculated limit of 
detection. 
III. CONCLUSION AND PERSPECTIVES 
    These results are very promising and validate the magnetic 
detection of SPNs within the developed first prototype device. 
Experiments to validate the magnetic detection of biological 
entities with the PCB structure are in progress. We hope to 
achieve rapid LoC magnetic immunoassays for healthcare or 
environmental purposes in a close future. 
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